相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。OCT Signs of Early Atrophy in Age-Related Macular Degeneration: Interreader Agreement Classification of Atrophy Meetings Report 6
Zhichao Wu et al.
OPHTHALMOLOGY RETINA (2022)
Imaging Features Associated with Progression to Geographic Atrophy in Age-Related Macular Degeneration Classification of Atrophy Meeting Report 5
Glenn J. Jaffe et al.
OPHTHALMOLOGY RETINA (2021)
End-of-Study Results for the Ladder Phase 2 Trial of the Port Delivery System with Ranibizumab for Neovascular Age-Related Macular Degeneration
Arshad M. Khanani et al.
OPHTHALMOLOGY RETINA (2021)
Spectral-Domain OCT-Based Prevalence and Progression of Macular Atrophy in the HARBOR Study for Neovascular Age-Related Macular Degeneration
Shamika Gune et al.
OPHTHALMOLOGY (2020)
Macular Atrophy in Neovascular Age-Related Macular Degeneration A Randomized Clinical Trial Comparing Ranibizumab and Aflibercept (RIVAL Study)
Mark C. Gillies et al.
OPHTHALMOLOGY (2020)
Anti-Vascular Endothelial Growth Factor Use and Atrophy in Neovascular Age-Related Macular Degeneration Systematic Literature Review and Expert Opinion
SriniVas R. Sadda et al.
OPHTHALMOLOGY (2020)
Incidence of Macular Atrophy after Untreated Neovascular Age-Related Macular Degeneration Age-Related Eye Disease Study Report 40
Panos G. Christakis et al.
OPHTHALMOLOGY (2020)
Spectral-Domain OCT Analysis of Risk Factors for Macular Atrophy Development in the HARBOR Study for Neovascular Age-Related Macular Degeneration
SriniVas R. Sadda et al.
OPHTHALMOLOGY (2020)
Macular Morphology and Visual Acuity in Year Five of the Comparison of Age-related Macular Degeneration Treatments Trials
Glenn J. Jaffe et al.
OPHTHALMOLOGY (2019)
The Port Delivery System with Ranibizumab for Neovascular Age-Related Macular Degeneration Results from the Randomized Phase 2 Ladder Clinical Trial
Peter A. Campochiaro et al.
OPHTHALMOLOGY (2019)
Intralesional Macular Atrophy in Anti-Vascular Endothelial Growth Factor Therapy for Age-Related Macular Degeneration in the IVAN Trial
Clare Bailey et al.
OPHTHALMOLOGY (2019)
Real-World Vision in Age-Related Macular Degeneration Patients Treated with Single Anti-VEGF Drug Type for 1 Year in the IRIS Registry
Prethy Rao et al.
OPHTHALMOLOGY (2018)
Macular Atrophy in the HARBOR Study for Neovascular Age-Related Macular Degeneration
SriniVas R. Sadda et al.
OPHTHALMOLOGY (2018)
Consensus Definition for Atrophy Associated with Age-Related Macular Degeneration on OCT Classification of Atrophy Report 3
Srinivas R. Sadda et al.
OPHTHALMOLOGY (2018)
Real-world visual outcomes in patients with neovascular age-related macular degeneration receiving aflibercept at fixed intervals as per UK licence
Mehmet Ozturk et al.
CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2018)
Macular Atrophy in Neovascular Age-Related Macular Degeneration with Monthly versus Treat-and-Extend Ranibizumab
Nizar S. Abdelfattah et al.
OPHTHALMOLOGY (2017)
Caregiver perceptions about the impact of caring for patients with wet age-related macular degeneration
M. Vukicevic et al.
EYE (2016)
Disease Burden in the Treatment of Age-Related Macular Degeneration: Findings From a Time-and-Motion Study
Jonathan L. Prenner et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2015)
Macular Atrophy Progression and 7-Year Vision Outcomes in Subjects From the ANCHOR, MARINA, and HORIZON Studies: the SEVEN-UP Study
Robert B. Bhisitkul et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2015)
Growth of Geographic Atrophy in the Comparison of Age-related Macular Degeneration Treatments Trials
Juan E. Grunwald et al.
OPHTHALMOLOGY (2015)
Caregiver Burden in Patients Receiving Ranibizumab Therapy for Neovascular Age Related Macular Degeneration
Rishma Gohil et al.
PLOS ONE (2015)
Multi-country real-life experience of anti-vascular endothelial growth factor therapy for wet age-related macular degeneration
Frank G. Holz et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2015)
Current barriers to treatment for wet age-related macular degeneration (wAMD): findings from the wAMD patient and caregiver survey
Monica Varano et al.
CLINICAL OPHTHALMOLOGY (2015)
Risk of Geographic Atrophy in the Comparison of Age-related Macular Degeneration Treatments Trials
Juan E. Grunwald et al.
OPHTHALMOLOGY (2014)
Treatment patterns, visual acuity and quality-of-life outcomes of the WAVE study - A noninterventional study of ranibizumab treatment for neovascular age-related macular degeneration in Germany
Robert P. Finger et al.
ACTA OPHTHALMOLOGICA (2013)
Alternative treatments to inhibit VEGF in age-related choroidal neovascularisation: 2-year findings of the IVAN randomised controlled trial
Usha Chakravarthy et al.
LANCET (2013)
Twelve-Month Efficacy and Safety of 0.5 mg or 2.0 mg Ranibizumab in Patients with Subfoveal Neovascular Age-related Macular Degeneration
Brandon G. Busbee et al.
OPHTHALMOLOGY (2013)
Circularity Index as a Risk Factor for Progression of Geographic Atrophy
Amitha Domalpally et al.
OPHTHALMOLOGY (2013)
CHANGES IN VISUAL ACUITY IN PATIENTS WITH WET AGE-RELATED MACULAR DEGENERATION TREATED WITH INTRAVITREAL RANIBIZUMAB IN DAILY CLINICAL PRACTICE The LUMIERE Study
Salomon Y. Cohen et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2013)
Ranibizumab and Bevacizumab for Treatment of Neovascular Age-Related Macular Degeneration
Daniel F. Martin et al.
OPHTHALMOLOGY (2012)
Intravitreal Aflibercept (VEGF Trap-Eye) in Wet Age-related Macular Degeneration
Jeffrey S. Heier et al.
OPHTHALMOLOGY (2012)
Semiautomated Image Processing Method for Identification and Quantification of Geographic Atrophy in Age-Related Macular Degeneration
Steffen Schmitz-Valckenberg et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2011)
Ranibizumab for neovascular age-related macular degeneration
Philip J. Rosenfeld et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Ranibizumab versus verteporfin for neovascular age-related macular degeneration
David M. Brown et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
分享论文
